Table 1 The comparison of clinic and laboratory characteristic in patients between hepatic significant fibrosis and no/minor fibrosis.
Variables | Age <3years (n = 116) | Age ≥ 3years (n = 67) | ||||
|---|---|---|---|---|---|---|
S0-1(n = 31) | S2-4(n = 85) | P-Value | S0-1(n = 26) | S2-4(n = 41) | P-Value | |
Age (month) | 17.1 ± 10.8 | 10 ± 8.5 | P < 0.001 | 89.4 ± 51.7 | 81.9 ± 35.7 | P = 0.48 |
GP73 (ng/ml) | 162 ± 78.5 | 239 ± 82.3 | P < 0.001 | 128.4 ± 81.7 | 149.6 ± 58.8 | P = 0.22 |
TB (umol/L) | 19.1 ± 30.6 | 142 ± 108 | P < 0.001 | 48 ± 65 | 43.3 ± 70.8 | P = 0.61 |
ALT (U/L) | 207 ± 184 | 257 ± 296 | P = 0.493 | 203 ± 460 | 162 ± 182 | P = 0.62 |
AST (U/L) | 169 ± 157 | 355 ± 347 | P = 0.002 | 117.6 ± 136 | 176.5 ± 192 | P = 0.12 |
ALB (g/L) | 43.3 ± 2.3 | 40.2 ± 4.7 | P = 0.001 | 44.3 ± 3.1 | 41.7 ± 5.2 | P = 0.028 |
GGT (U/L) | 93.8 ± 114 | 140 ± 179 | P = 0.016 | 209.6 ± 378 | 109.7 ± 144 | P = 0.425 |
TBA (umol/l) | 42 ± 106 | 180 ± 111 | P < 0.001 | 98.6 ± 164 | 69.8 ± 111.5 | P = 0.62 |
PLT (10*9/L) | 299 ± 146 | 326 ± 166 | P = 0.419 | 225.8 ± 95 | 223 ± 112 | P = 0.918 |
Inflammation | 0.94 ± 0.73 | 2.2 ± 0.88 | P < 0.001 | 1 ± 0.6 | 1.8 ± 1 | P = 0.001 |